📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
1 analysed today
FollowTelegram
1
Today
151,861
All-time analysed
43,535
Positive
6,743
Negative
92,746
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
147 announcements match the current filters (relevance ≥ 5).
Piramal Finance to sell 14.72% stake in Shriram Life Insurance for Rs 600 crore
Piramal Finance Limited has entered into a share purchase agreement to divest its entire 14.72% equity stake in Shriram Life Insurance Company Ltd (SLIC). The stake is being sold to Sanlam Emerging Markets (Mauritius) Limited for a total consideration of Rs 600 crore. This move is part of Piramal's strategic focus on monetizing non-core assets to strengthen its balance sheet. The transaction is expected to close by March 31, 2026, subject to IRDAI and other regulatory approvals.
Key Highlights
Sale of 14.72% equity stake in Shriram Life Insurance for Rs 600 crore
Divested asset contributed only 0.12% (Rs 12.68 crore) to FY25 revenue via dividends
Transaction expected to conclude in Q4 FY26 pending IRDAI approval
Proceeds intended to strengthen the balance sheet and exit non-core investments
Buyer is Sanlam Emerging Markets (Mauritius) Limited, part of the South African Sanlam Group
👀 What to Watch
Investors should view this as a positive value-unlocking move that streamlines the company's focus on its core lending business. Monitor the timely receipt of regulatory approvals and the deployment of the Rs 600 crore cash inflow.
Piramal Finance Investor Presentation: AUM up 22% YoY to ₹91,447 Cr
Piramal Finance Limited has released an investor presentation highlighting its Q2 FY26 performance and strategic outlook. The company's consolidated AUM grew by 22% YoY to ₹91,447 Cr. Retail AUM now constitutes 82% of the total AUM. Consolidated PAT increased by 101% YoY to ₹327 Cr, while the growth business PBT reached ₹344 Cr, up 98% YoY. The company aims for RoAUM >3% with a target AUM-to-equity of 4.5-5.0x.
Key Highlights
Consolidated AUM up 22% YoY to ₹91,447 Cr
Retail AUM constitutes 82% of total AUM
Consolidated PAT up 101% YoY to ₹327 Cr
Growth business PBT up 98% YoY to ₹344 Cr
Legacy AUM is ₹5,448 Cr, representing 6% of total AUM
👀 What to Watch
Review the investor presentation for detailed insights into Piramal Finance's strategy and financial performance. Monitor the company's progress towards achieving its RoAUM and AUM-to-equity targets.
Piramal Finance Investor Presentation on Investec AI Unmasked Conference
Piramal Finance Limited is presenting to investors at the 'Investec AI Unmasked - The Real & Possible Conference' on December 15, 2025. The investor presentation highlights the company's journey, tech approach, and AI integration. Piramal Finance's retail AUM has grown to ₹74,704 Cr, now representing 94% of the total AUM. The company has expanded its product portfolio to 13 products and has a presence in 429 cities across 26 states.
Key Highlights
Retail AUM is ₹74,704 Cr
Growth book is 94% of total AUM
Expanded product portfolio to 13 products
517 branches across the country
Cross-sell contributes to 11% of all disbursements
👀 What to Watch
Review the investor presentation to understand Piramal Finance's growth strategy and AI initiatives. Monitor the company's progress in expanding its retail business and improving operational efficiency.
Thirumalai Chemicals' US Subsidiary Starts Pre-Commissioning of $255M West Virginia Facility
Thirumalai Chemicals' US subsidiary, TCL Specialties LLC, has commenced pre-commissioning and start-up activities at its new integrated manufacturing facility in West Virginia. The project, representing a $255 million investment, includes a 40,000 tons/yr Maleic Anhydride (MAN) plant and a 30,000 tons/yr Food Ingredients plant. The company expects the MAN unit to start by the end of 2025, with full stabilization of all units by H1 2026. To lead this expansion, industry veteran Vinod Tiwari has been appointed as CEO and Director of the US subsidiary.
Key Highlights
Total investment of approximately $255 million in the West Virginia facility, funded via debt and equity.
Facility includes a Maleic Anhydride plant (>40,000 tons/yr) and a Food Ingredients plant (>30,000 tons/yr).
Strategic location in the Marcellus-Utica shale region provides a significant feedstock advantage for n-Butane.
Phased startup planned with the MAN unit beginning by end of 2025 and full operations by H1 2026.
Appointment of Vinod Tiwari, who has 40 years of global experience, as CEO of TCL Specialties LLC.
👀 What to Watch
Investors should track the successful commissioning of the MAN unit by late 2025, as this major expansion into the US market is a significant growth driver for the company's global revenue.
Piramal Finance gets nod for NCD coupon rate modification (ISINs INE516Y07014 & INE516Y07063)
Piramal Finance Limited has received in-principle approval from stock exchanges for modifying the coupon rate of its Non-Convertible Debentures (NCDs) issued under ISINs INE516Y07014 and INE516Y07063. Approvals were granted by the National Stock Exchange of India on December 10, 2025, and BSE Limited on November 27, 2025. The company executed addenda to the Information Memorandum dated December 18, 2018, and March 8, 2019, respectively. Final listing will proceed upon receipt of modified ISIN letters from the Depositories.
Key Highlights
Received in-principle approval for coupon rate modification on NCDs
ISINs affected: INE516Y07014 and INE516Y07063
NSE approval date: December 10, 2025
BSE approval date: November 27, 2025
Addendum to Information Memorandum executed on December 11, 2025
👀 What to Watch
Investors holding NCDs under ISINs INE516Y07014 and INE516Y07063 should monitor the company's announcements regarding the final coupon rate and listing. Review the updated Information Memorandum for details.
Piramal Finance Denies Reports of Keertana Acquisition for Gold Loan Foray
Piramal Finance Limited has officially clarified to the National Stock Exchange that recent media reports regarding its interest in acquiring Keertana for a gold loan foray are factually incorrect. The company responded to a clarification request following an Economic Times article dated December 9, 2025. Management stated that there is no undisclosed material information pending that could impact price or volume behavior. The company maintains that recent equity share price movements are entirely market-driven and outside of management's control.
Key Highlights
Categorically denied the news report published on December 9, 2025, regarding the Keertana acquisition.
Confirmed that no material information or announcement is pending disclosure under SEBI Regulation 30.
Attributed recent stock price and volume fluctuations to market forces rather than internal corporate developments.
Reiterated commitment to ongoing compliance with SEBI Listing Regulations for all future material events.
👀 What to Watch
Investors should ignore the speculative acquisition rumors and focus on the company's official disclosures and quarterly financial performance.
TIRUMALCHM: Malaysia Unit Outage Prolonged; ₹235 Cr Revenue Impact
Thirumalai Chemicals' step-down subsidiary, Optimistic Organic Sdn Bhd (OOSB) in Malaysia, faces a prolonged outage of its Maleic Anhydride unit due to machinery failure. This is expected to reduce consolidated revenue by ₹235 Cr annually, representing 9.6% of FY25 consolidated revenue. The outage has already resulted in an approximate revenue reduction of ₹118 crore in H1 FY26. The Maleic Anhydride unit constituted about 4% (₹140 crore) of the consolidated net worth as at the end of FY25. The derivatives plant of OOSB continues to operate.
Key Highlights
Maleic Anhydride unit outage expected to reduce consolidated revenue by ₹235 Cr annually.
Maleic Anhydride business contributed about 9.6% of FY25 consolidated revenue.
Outage resulted in approximately ₹118 crore reduction in revenue in H1 FY26.
Maleic Anhydride unit constituted about ₹140 crore of the consolidated net worth as at end of FY25.
👀 What to Watch
Investors should closely monitor the progress of the repairs and the impact on Thirumalai Chemicals' consolidated financials. Consider the reduced revenue guidance when evaluating the company's future performance.
